Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-01-25

FDA Approved: OLOPATADINE HYDROCHLORIDE — Supplemental Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

FDA approved Alembic Pharmaceuticals Limited's supplemental application for olopatadine hydrochloride (ANDA209420), authorizing changes under the supplemental N…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OLOPATADINE HYDROCHLORIDE (olopatadine hydrochloride)

Snippet

SUPPL AP for OLOPATADINE HYDROCHLORIDE (OLOPATADINE HYDROCHLORIDE)